Ginkgo Bioworks Holdings (DNA) Income towards Parent Company (2020 - 2026)

Ginkgo Bioworks Holdings posted quarterly Income towards Parent Company of -$6.5 million for Q1 2026, up 14.63% year-on-year from -$5.7 million in Q1 2025, and up 91.92% on a QoQ basis from -$80.8 million in Q4 2025.

Ginkgo Bioworks Holdings (DNA) has 7 years of Income towards Parent Company data on file, last reported at -$6.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Income towards Parent Company rose 14.63% year-over-year to -$6.5 million; the trailing twelve-month figure through Mar 2026 stood at -$228.3 million (up 41.27% YoY), and the FY2025 full-year result was -$312.8 million, up 42.83% from the prior year.
  • Income towards Parent Company for Q1 2026 stood at -$6.5 million, up from -$80.8 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at -$6.5 million in Q1 2026 and bottomed at -$670.6 million in Q2 2022.
  • The 5-year median for Income towards Parent Company is -$173.1 million (2022), against an average of -$222.5 million.
  • The widest annual swing landed in 2022, when Income towards Parent Company sank 1131.22%; it then soared 95.39% in 2025.
  • A 5-year view of Income towards Parent Company shows it stood at -$173.1 million in 2022, then retreated by 22.31% to -$211.7 million in 2023, then soared by 49.2% to -$107.5 million in 2024, then advanced by 24.91% to -$80.8 million in 2025, then soared by 91.92% to -$6.5 million in 2026.
  • The last three Income towards Parent Company figures came in at -$6.5 million (Q1 2026), -$80.8 million (Q4 2025), and -$80.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Ginkgo Bioworks Holdings 542.03 Mn 542.03 Mn 16.38 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -6.53 Mn
Dec 31, 2025 -80.75 Mn
Sep 30, 2025 -80.76 Mn
Jun 30, 2025 -60.30 Mn
Mar 31, 2025 -7.65 Mn
Dec 31, 2024 -107.53 Mn
Sep 30, 2024 -56.40 Mn
Jun 30, 2024 -217.18 Mn
Mar 31, 2024 -165.91 Mn
Dec 31, 2023 -211.69 Mn
Sep 30, 2023 -302.89 Mn
Jun 30, 2023 -173.32 Mn
Mar 31, 2023 -204.97 Mn
Dec 31, 2022 -173.08 Mn
Sep 30, 2022 -670.13 Mn
Jun 30, 2022 -670.57 Mn
Mar 31, 2022 -592.59 Mn
Dec 31, 2021 -1.60 Bn
Sep 30, 2021 -102.41 Mn
Jun 30, 2021 -54.46 Mn
Mar 31, 2021 -74.78 Mn
Dec 31, 2020 -46.40 Mn
Sep 30, 2020 -26.13 Mn